COVID-19 Coronavirus Research Tools
Pre-Made AAVs Center
Neuronal Tracing Tool

BrainVTA

Construction and Packaging Service of virus Vector

Construction and Packaging Services of AAV

Large scale AAV production

AAV9-Retro mediates efficient transduction with axon terminal
AAV9-Retro was used for efficient retrograde transduction. (From BrainVTA)
The viruses used in this article from BrainVTA are in the table below
Custom-Made AAV  AAV9-Retro inserted with peptide sequence (LADQDYTKTA)
Kunzhang Lin, Xin Zhong, Lei Li, Min Ying, Tian Yang, Zhijian Zhang, Xiaobin He, Fuqiang Xu
Pub Date: 2020-10-14, DOI: 10.1186/s13041-020-00679-1, Email: [email protected]
Recombinant adeno-associated viruses (rAAVs), particularly those that permit efficient gene transfer to neurons from axonal terminals or across the blood–brain barrier, are useful vehicles for structural and functional studies of the neural circuit and for the treatment of many gene-deficient brain diseases that need to compensate for the correct genes in every cell in the whole brain. However, AAVs with these two advantages have not been reported. Here, we describe a new capsid engineering method, which exploits the combination of different capsids and aims to yield a capsid that can provide more alternative routes of administration that are more suitable for the wide-scale transduction of the central nervous system (CNS). A new AAV variant, AAV9-Retro, was developed by inserting the 10-mer peptide fragment from AAV2-Retro into the capsid of AAV9, and the biodistribution properties were evaluated in mice. By intracranial and intravenous injection in the mice, we found that AAV9-Retro can retrogradely infect projection neurons with an efficiency comparable to that of AAV2-Retro and retains the characteristic of AAV9, which can be transported across the nervous system. Our strategy provides a new tool for the manipulation of neural circuits and future preclinical and clinical treatment of some neurological and neurodegenerative disorders.

Figure 1. Efficient retrograde transduction by rAAV9-Retro.
In this study, the authors reported a new AAV variant, AAV9-Retro can retrogradely infect projection neurons with an efficiency comparable to that of AAV2-Retro and retains the characteristic of AAV9, which can be transported across the nervous system. The strategy provides a new retrograde tool for the manipulation of neural circuits and future treatment of some neurological and neurodegenerative diseases.
 
BrainVTA offers viral vector construction & virus packaging services for AAV, LV, RABV, PRV, HSV and VSV that help researchers explore questions about genes, neurons, circuitry structure, function of brain network, mechanism and treatment of diseases.
If you have any needs, just email us at [email protected].


 

50% discount for Pre-Made AAVs